Expand CRVS Menu
CRVS MENU

CRVS Stock Posts


Upcoming Earnings

CRVS Corvus Pharmaceuticals1.97+0.07 (+3.7%)

Corvus Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±26.3% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±5.2%. View Expected Move (Conf Call: Mar 19 4:30 PM)
Upcoming Earnings

CRVS Corvus Pharmaceuticals1.480.00 (0.0%)

Corvus Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±8.7% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±5.8%. View Expected Move (Conf Call: Nov 7 4:30 PM)
Unusual Option Volume

CRVS Corvus Pharmaceuticals1.67-0.42 (-20.1%)

Corvus Pharmaceuticals trades 3,399 contracts. The highest volume is in the 19-Jan-24 2 calls, which is 19.8% above the current price. News: Corvus Pharmaceuticals Confirms Planned Initiation of Soquelitinib (CPI-818) Phase 3 Registrational Clinical Trial in Peripheral T Cell Lymphoma Following Meeting with FDA
View Details...
Unusual Option Volume

CRVS Corvus Pharmaceuticals2.36+0.22 (+10.3%)

Corvus Pharmaceuticals trades 2,710 contracts. The highest volume is in the 19-Jan-24 4 calls, which is 69.5% above the current price. News: Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
View Details...
Upcoming Earnings

CRVS Corvus Pharmaceuticals2.090.00 (0.0%)

Corvus Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±15.6% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.1%. View Expected Move (Conf Call: Aug 8 4:30 PM)
Unusual Option Volume

CRVS Corvus Pharmaceuticals2.59-0.76 (-22.7%)

Corvus Pharmaceuticals trades 2,551 contracts. The company has the following event: International Conference on Malignant Lymphoma on Jun 15, 2023. News: Corvus Pharmaceuticals Presents New CPI-818 Interim Data at the International Conference on Malignant Lymphoma
View Details...
Load Earlier Posts